KRAS and cancer: Plinabulin (BAL27862, 75, Figure 11) (Table 1) is a small-molecule MTA and is particularly active against Kirsten rat sarcoma viral analogue homologue (KRAS)-driven cancers, which are present in 30% of cancers and are associated with poor patient survival.